EWOOF — Stock Film
STOCK FILMSCENE 1/10EWOOF · $0.69
Stock Expert AI presents
EWOOF
Eastwood Bio-Medical Canada Inc
~3 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Eastwood Bio-Medical Canada Inc. A quick introduction.

On the stock market since 2018, it operates in the everyday-essentials business. Now — the numbers.

on the stock market since 2018
$47.8M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $1.6.

The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
Sales have been shrinking.

An average decline of 3% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$982K
2019
$718K
2020
$981K
2021
$1.3M
2022
$868K
2023
In the vault right now:
$0
DEBT: $62K
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
The stock has lost its spark0/10
Costs eat into the margin4/10
WORTH WATCHING

Cost Efficiency: As sales grow, profit fails to keep the same pace.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 57% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/1
The product is selling

Sales run at $868K a year. A small number, but proof the product has real buyers.

1
THE RISKS · 1/3
Small sales, big loss

A loss of $547K against $868K in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/3
Trading under $1

The stock sits at $0.69. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.

3
THE RISKS · 3/3
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, EWOOF sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: EWOOF is a high-risk stock — not yet profitable, and its future rides on its product catching on.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film